Impact of COVID-19 on the supply chain, demand and financial results
First written in FY2020. 8 of 18 entries say "Restated". Latest entry: FY2026.
Arisawa Mfg. moved to the "Worse" side of this theme in 2024, 4 years after the typical company in this theme (2020).
The whole theme swung hardest in 2025: 5 of 16 companies on the "Worse" side.
19 other companies' latest entry also says "Restated".
- FY2026RestatedAnnual report
「If a serious new infectious disease emerges and spreads, the group’s business performance could be affected by disruptions to the supply chain and production activities and adverse effects on the domestic economy and markets.」
The company continues to describe risks broadly in terms of serious new infectious diseases rather than COVID-19 specifically, along with responses such as infection-control measures and telework. - FY2025ReframedAnnual report
「If a serious new infectious disease emerges and spreads, the group’s business performance could be affected by disruptions to the supply chain and production activities and adverse effects on the domestic economy and markets.」
The company reorganized the risk disclosure from one centered on the spread of COVID-19 to a broader description of the impact of serious new infectious diseases on the supply chain, production activities, the economy and markets. - FY2025-H1SoftenedAnnual report
「During the interim consolidated accounting period, the Japanese economy remained on a moderate recovery trend, supported by the normalization of social and economic activity, improvements in employment and income conditions, and increased inbound demand.」
The disclosure shifted from the previous explanation centered on the spread of infection and the slowdown in economic activity to a description of the normalization of social and economic activity and a moderate recovery trend. - FY2024-Q3SoftenedAnnual report
「During the cumulative third-quarter consolidated period, social and economic activity continued to normalize from the effects of the COVID-19 pandemic, and the economy remained on a moderate recovery trend.」
The disclosure shifted from the previous explanation centered on the slowdown in economic activity caused by the spread of COVID-19 to a description of the normalization of social and economic activity from the pandemic and a moderate recovery trend in the economy. Uncertainty from other external factors continues. - FY2024-Q2SoftenedAnnual report
「During the cumulative second-quarter consolidated period, the Japanese economy saw further progress toward the normalization of economic activity as the impact of COVID-19 subsided.」
The company described the subsiding impact of COVID-19 and the normalization of economic activity, further reducing the previous risk explanation centered on the spread of infection and the slowdown in economic activity. - FY2024-Q1SoftenedAnnual report
「Although COVID-19 was reclassified as a Category 5 disease under the Infectious Diseases Control Act and economic activity moved toward normalization,」
Regarding COVID-19, the company described its reclassification under the Infectious Diseases Control Act and the normalization of economic activity, while the previous risk explanation centered on the spread of infection and the slowdown in economic activity has weakened. Uncertainty from other external factors continues. - FY2023-Q3RestatedAnnual report
「There were no significant changes to the assumptions, including those concerning the timing of containment of COVID-19, or to the accounting estimates described in the securities report for the previous fiscal year.」
The company stated that there had been no significant changes from the previous fiscal year to the accounting assumptions concerning the timing of containment of COVID-19 and related matters. - FY2023-Q2RestatedAnnual report
「There were no significant changes to the assumptions, including those concerning the timing of containment of COVID-19, or to the accounting estimates described in the securities report for the previous fiscal year.」
The company stated that there had been no significant changes to the accounting assumptions concerning the timing of containment of COVID-19 and related matters. - FY2023-Q1ReframedAnnual report
「During the cumulative first quarter under review, Japan's economy remained uncertain despite progress in easing restrictions on activities related to COVID-19. Concerns about a resurgence of infections caused by variants, China's zero-COVID policy, the prolonged situation in Ukraine, and rapid yen depreciation led to surging energy and raw material prices.」
The company updated its explanation of pandemic-related uncertainty to include the easing of restrictions on activities, renewed spread caused by variants and China’s zero-COVID policy. It stated that there had been no significant change in the assumptions used in accounting estimates. - FY2022RestatedAnnual report
「Although vaccinations against COVID-19 have progressed and there has been movement toward containment, the timing of containment remains unforeseeable, the economic impact is prolonged, and the outlook remains uncertain.」
While referring to progress toward containment through vaccinations, the company continues to disclose uncertainty over the timing of containment, a prolonged economic impact, and the risk of an impact on the supply chain and production activities. - FY2022-Q3ReframedAnnual report
「During the cumulative third-quarter consolidated period, there were signs that severe conditions were easing as COVID-19 vaccinations progressed. However, the emergence of new variants left the situation unpredictable, and the Japanese economy remained subject to an uncertain outlook.」
While referring to the progress of vaccinations and signs of an easing in economic conditions, the company stated that the impact of the pandemic and uncertainty over the outlook continued because of the emergence of new variants. - FY2022-Q2RestatedAnnual report
「During the cumulative second-quarter consolidated period, the Japanese economy remained in severe conditions as the state of emergency was extended due to the spread of COVID-19, restraining economic activity.」
The company described severe economic conditions resulting from the extension of the state of emergency and restrictions on economic activity, and continued to indicate the impact of COVID-19 on the economy and business performance. - FY2022-Q1RestatedAnnual report
「During the cumulative first quarter under review, Japan's economy was significantly affected by the stagnation of economic activity caused by the spread of COVID-19. Although vaccinations against COVID-19 had begun, uncertainty about the timing of containing the spread remained, uncertainty about the outlook was high, and concerns persisted that the impact on corporate performance would be prolonged.」
While noting the change represented by the start of vaccinations, the company continues to disclose uncertainty over when the pandemic will be contained, the slowdown in economic activity and concern about a prolonged impact on corporate performance. - FY2021RestatedAnnual report
「Although vaccination against COVID-19 has begun and there has been progress toward containment, the timing of containment remains unforeseeable, raising concern that the impact on the economy will be prolonged, and the outlook remains uncertain.」
While noting the change represented by the start of vaccinations, the company continues to disclose uncertainty over when the pandemic will be contained, concern about a prolonged economic impact, and the risk of an impact on the supply chain and production activities. - FY2021-Q3RestatedAnnual report
「During the cumulative third quarter under review, Japan's economy was in an extremely severe condition as economic activity stagnated due to the spread of COVID-19 infections. In addition, as the timing of containment remained uncertain, concerns grew that the economic impact would be prolonged, and the economy continued to operate in an uncertain environment.」
The slowdown in economic activity caused by the spread of COVID-19, uncertainty over when it will be contained and concern about a prolonged impact continue. The assumption used in accounting estimates, that the impact will continue for at least the current consolidated fiscal year, has been reiterated. - FY2021-Q2WorsenedAnnual report
「Regarding the assumptions concerning the impact of COVID-19 described in the additional information section of the securities report for the previous consolidated fiscal year, the company had assumed a range that included early containment by the end of September 2020. In light of subsequent infection trends, the company changed part of its assumptions to assume that the impact would continue for at least the current consolidated fiscal year.」
Regarding the impact of COVID-19, the company changed its assumption from one that included early containment to one that assumes the impact will continue for at least the current consolidated fiscal year. The disclosure also describes the slowdown in economic activity and the difficulty of forecasting when the outbreak will be contained. - FY2021-Q1WorsenedAnnual report
「During the cumulative first-quarter consolidated period, the Japanese economy was severely affected by a slowdown in economic activity resulting from the global spread of COVID-19. With no clear prospect for when the spread would be contained, uncertainty about the outlook was strong, and concern remained that the impact on corporate performance could be prolonged.」
The risk disclosure became more severe, shifting from the explanation at the end of the previous fiscal year that there was no significant impact on production and only a limited impact on sales to a description of the global spread of the virus, the resulting slowdown in economic activity, strong uncertainty and concern about a prolonged impact on corporate performance. - FY2020First statedAnnual report
「Although COVID-19 is moving toward containment, if it persists for an extended period or spreads again, disruption to the supply chain and production activities and adverse effects on the domestic economy and markets could affect the Group's financial results. The impact on the Group's businesses has so far been limited in production and sales. The upper end of the range assumes early containment by the end of September 2020, while the lower end assumes that containment is not achieved by the end of March 2021.」
Identifies the spread of COVID-19 as a new risk that could affect the supply chain, production activities, the domestic economy and markets, and financial results. At the time of filing, the impact on production was not significant and the impact on sales was limited.